Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison

10.4137/CMO.S13671

Saved in:

Bibliographic Details
Main Authors:	Tan, P.S., Haaland, B., Montero, A.J., Kyriakopoulos, C.E., Lopes, G.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2016
Subjects:	Abiraterone acetate Enzalutamide mCRPC Metastatic castration-resistant prostate cancer Post-docetaxel
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/126501
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-126501
record_format	dspace
spelling	sg-nus-scholar.10635-1265012023-10-26T21:27:36Z Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison Tan, P.S. Haaland, B. Montero, A.J. Kyriakopoulos, C.E. Lopes, G. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Abiraterone acetate Enzalutamide mCRPC Metastatic castration-resistant prostate cancer Post-docetaxel 10.4137/CMO.S13671 Clinical Medicine Insights: Oncology 8 29-36 2016-09-06T03:00:02Z 2016-09-06T03:00:02Z 2014-03-16 Article Tan, P.S., Haaland, B., Montero, A.J., Kyriakopoulos, C.E., Lopes, G. (2014-03-16). Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison. Clinical Medicine Insights: Oncology 8 : 29-36. ScholarBank@NUS Repository. https://doi.org/10.4137/CMO.S13671 11795549 http://scholarbank.nus.edu.sg/handle/10635/126501 000215745000004 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Abiraterone acetate Enzalutamide mCRPC Metastatic castration-resistant prostate cancer Post-docetaxel
spellingShingle	Abiraterone acetate Enzalutamide mCRPC Metastatic castration-resistant prostate cancer Post-docetaxel Tan, P.S. Haaland, B. Montero, A.J. Kyriakopoulos, C.E. Lopes, G. Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison
description	10.4137/CMO.S13671
author2	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Tan, P.S. Haaland, B. Montero, A.J. Kyriakopoulos, C.E. Lopes, G.
format	Article
author	Tan, P.S. Haaland, B. Montero, A.J. Kyriakopoulos, C.E. Lopes, G.
author_sort	Tan, P.S.
title	Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison
title_short	Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison
title_full	Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison
title_fullStr	Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison
title_full_unstemmed	Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison
title_sort	hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mcrpc) post-docetaxel-an indirect comparison
publishDate	2016
url	http://scholarbank.nus.edu.sg/handle/10635/126501
_version_	1781790155789565952

Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison

Similar Items